Repetitive Transcranial Magnetic Stimulation of the Posterior Parietal Cortex in Patients Suffering From Gilles de la Tourette Syndrome (rTMSPPCGT)
Primary Purpose
Gilles de la Tourette Syndrome, Tics
Status
Terminated
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
rTMS
Sham rTMS
Sponsored by
About this trial
This is an interventional treatment trial for Gilles de la Tourette Syndrome focused on measuring Gilles de la Tourette syndrome, Tics, Transcranial magnetic stimulation
Eligibility Criteria
Inclusion Criteria:
- Gilles de la Tourette syndrome as defined by DSM IV-R
- Yale Global Tics Severity Scale (YGTSS) score between 30 et 60
- Premonitory sensations (" urge to move ")
- Affiliated to the French social security regime
- Ability to give informed consent
Exclusion Criteria:
- rTMS : epilepsy, craniotomy scar, pacemaker or neural stimulator, metal implants or foreign bodies, claustrophobia, pregnancy
- Cognitive impairment (MMS ≤ 24/30)
- Axis I disorders according to DSM IV-R : psychosis or history of psychosis, bipolar illness, major depressive disorder, addictions (except to nicotine)
- Impulse control disorders
- Other chronic debilitating illnesses
- Unability to give informed consent
- Participation in another clinical trial
Sites / Locations
- Inserm U975
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Stimulation
Sham stimulation
Arm Description
Repetitive transcranial stimulation of the posterior parietal cortex
Outcomes
Primary Outcome Measures
Yale global tic severity scale (YTGSS)
Secondary Outcome Measures
Full Information
NCT ID
NCT01043549
First Posted
January 4, 2010
Last Updated
February 24, 2016
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
1. Study Identification
Unique Protocol Identification Number
NCT01043549
Brief Title
Repetitive Transcranial Magnetic Stimulation of the Posterior Parietal Cortex in Patients Suffering From Gilles de la Tourette Syndrome
Acronym
rTMSPPCGT
Official Title
Repetitive Transcranial Magnetic Stimulation of the Posterior Parietal Cortex in Patients Suffering From Gilles de la Tourette Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
February 2016
Overall Recruitment Status
Terminated
Why Stopped
lake of efficacy
Study Start Date
February 2010 (undefined)
Primary Completion Date
September 2012 (Actual)
Study Completion Date
September 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Repetitive transcranial stimulation (rTMS) of the posterior parietal cortex will be applied daily over five days in adult Gilles de la Tourette patients. This approach aims at reducing premonitory sensations believed to induce tics. Patients will be randomized to an active or placebo (sham) group in a crossover design.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gilles de la Tourette Syndrome, Tics
Keywords
Gilles de la Tourette syndrome, Tics, Transcranial magnetic stimulation
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Non-Randomized
Enrollment
5 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Stimulation
Arm Type
Active Comparator
Arm Description
Repetitive transcranial stimulation of the posterior parietal cortex
Arm Title
Sham stimulation
Arm Type
Sham Comparator
Intervention Type
Device
Intervention Name(s)
rTMS
Intervention Description
Repetitive transcranial stimulation of the posterior parietal cortex
Intervention Type
Device
Intervention Name(s)
Sham rTMS
Intervention Description
Repetitive transcranial stimulation of the posterior parietal cortex
Primary Outcome Measure Information:
Title
Yale global tic severity scale (YTGSS)
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Gilles de la Tourette syndrome as defined by DSM IV-R
Yale Global Tics Severity Scale (YGTSS) score between 30 et 60
Premonitory sensations (" urge to move ")
Affiliated to the French social security regime
Ability to give informed consent
Exclusion Criteria:
rTMS : epilepsy, craniotomy scar, pacemaker or neural stimulator, metal implants or foreign bodies, claustrophobia, pregnancy
Cognitive impairment (MMS ≤ 24/30)
Axis I disorders according to DSM IV-R : psychosis or history of psychosis, bipolar illness, major depressive disorder, addictions (except to nicotine)
Impulse control disorders
Other chronic debilitating illnesses
Unability to give informed consent
Participation in another clinical trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andreas Hartmann, MD
Organizational Affiliation
Institut National de la Santé Et de la Recherche Médicale, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
Inserm U975
City
Paris
ZIP/Postal Code
75013
Country
France
12. IPD Sharing Statement
Learn more about this trial
Repetitive Transcranial Magnetic Stimulation of the Posterior Parietal Cortex in Patients Suffering From Gilles de la Tourette Syndrome
We'll reach out to this number within 24 hrs